BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 35492241)

  • 1. LEAP2 reduces postprandial glucose excursions and
    Hagemann CA; Jensen MS; Holm S; Gasbjerg LS; Byberg S; Skov-Jeppesen K; Hartmann B; Holst JJ; Dela F; Vilsbøll T; Christensen MB; Holst B; Knop FK
    Cell Rep Med; 2022 Apr; 3(4):100582. PubMed ID: 35492241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver-expressed antimicrobial peptide 2 functions independently of growth hormone secretagogue receptor in calorie-restricted mice.
    Islam MN; Zhang W; Sakai K; Nakazato Y; Tanida R; Sakoda H; Takei T; Takao T; Nakazato M
    Peptides; 2022 May; 151():170763. PubMed ID: 35151767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GHSR controls food deprivation-induced activation of CRF neurons of the hypothalamic paraventricular nucleus in a LEAP2-dependent manner.
    Fernandez G; Cabral A; De Francesco PN; Uriarte M; Reynaldo M; Castrogiovanni D; Zubiría G; Giovambattista A; Cantel S; Denoyelle S; Fehrentz JA; Tolle V; Schiöth HB; Perello M
    Cell Mol Life Sci; 2022 May; 79(5):277. PubMed ID: 35504998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth hormone secretagogue receptor signalling affects high-fat intake independently of plasma levels of ghrelin and LEAP2, in a 4-day binge eating model.
    Cornejo MP; Castrogiovanni D; Schiöth HB; Reynaldo M; Marie J; Fehrentz JA; Perello M
    J Neuroendocrinol; 2019 Oct; 31(10):e12785. PubMed ID: 31469195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LEAP2 deletion in mice enhances ghrelin's actions as an orexigen and growth hormone secretagogue.
    Shankar K; Metzger NP; Singh O; Mani BK; Osborne-Lawrence S; Varshney S; Gupta D; Ogden SB; Takemi S; Richard CP; Nandy K; Liu C; Zigman JM
    Mol Metab; 2021 Nov; 53():101327. PubMed ID: 34428557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LEAP2 changes with body mass and food intake in humans and mice.
    Mani BK; Puzziferri N; He Z; Rodriguez JA; Osborne-Lawrence S; Metzger NP; Chhina N; Gaylinn B; Thorner MO; Thomas EL; Bell JD; Williams KW; Goldstone AP; Zigman JM
    J Clin Invest; 2019 Sep; 129(9):3909-3923. PubMed ID: 31424424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a novel fluorescent ligand of growth hormone secretagogue receptor based on the N-Terminal Leap2 region.
    Barrile F; M'Kadmi C; De Francesco PN; Cabral A; García Romero G; Mustafá ER; Cantel S; Damian M; Mary S; Denoyelle S; Banères JL; Marie J; Raingo J; Fehrentz JA; Perelló M
    Mol Cell Endocrinol; 2019 Dec; 498():110573. PubMed ID: 31499133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postprandial Increases in Liver-Gut Hormone LEAP2 Correlate with Attenuated Eating Behavior in Adults Without Obesity.
    Bhargava R; Luur S; Rodriguez Flores M; Emini M; Prechtl CG; Goldstone AP
    J Endocr Soc; 2023 Jun; 7(7):bvad061. PubMed ID: 37287649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of POMC neurons in LEAP2 regulation of food intake and body weight.
    Chu G; Peng H; Yu N; Zhang Y; Lin X; Lu Y
    Front Endocrinol (Lausanne); 2022; 13():932761. PubMed ID: 36387867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-Terminal Liver-Expressed Antimicrobial Peptide 2 (LEAP2) Region Exhibits Inverse Agonist Activity toward the Ghrelin Receptor.
    M'Kadmi C; Cabral A; Barrile F; Giribaldi J; Cantel S; Damian M; Mary S; Denoyelle S; Dutertre S; Péraldi-Roux S; Neasta J; Oiry C; Banères JL; Marie J; Perello M; Fehrentz JA
    J Med Chem; 2019 Jan; 62(2):965-973. PubMed ID: 30543423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intestinal expression profiles and hepatic expression of LEAP2, ghrelin and their common receptor, GHSR, in humans.
    Englund A; Gilliam-Vigh H; Suppli MP; Gasbjerg LS; Vilsbøll T; Knop FK
    Peptides; 2024 Jul; 177():171227. PubMed ID: 38657907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LEAP2 Is an Endogenous Antagonist of the Ghrelin Receptor.
    Ge X; Yang H; Bednarek MA; Galon-Tilleman H; Chen P; Chen M; Lichtman JS; Wang Y; Dalmas O; Yin Y; Tian H; Jermutus L; Grimsby J; Rondinone CM; Konkar A; Kaplan DD
    Cell Metab; 2018 Feb; 27(2):461-469.e6. PubMed ID: 29233536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver-Expressed Antimicrobial Peptide 2 antagonizes the insulinostatic effect of ghrelin in rat isolated pancreatic islets.
    Bayle M; Péraldi-Roux S; Gautheron G; Cros G; Oiry C; Neasta J
    Fundam Clin Pharmacol; 2022 Apr; 36(2):375-377. PubMed ID: 34449915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Novel Truncated Liver Enriched Antimicrobial Peptide-2 Palmitoylated at its N-Terminal Antagonizes Effects of Ghrelin.
    Holá L; Železná B; Karnošová A; Kuneš J; Fehrentz JA; Denoyelle S; Cantel S; Blechová M; Sýkora D; Myšková A; Maletínská L
    J Pharmacol Exp Ther; 2022 Nov; 383(2):129-136. PubMed ID: 36198495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pre-prandial plasma liver-expressed antimicrobial peptide 2 (LEAP2) concentration in humans is inversely associated with hunger sensation in a ghrelin independent manner.
    Andreoli MF; Fittipaldi AS; Castrogiovanni D; De Francesco PN; Valdivia S; Heredia F; Ribet-Travers C; Mendez I; Fasano MV; Schioth HB; Doi SA; Habib AM; Perello M
    Eur J Nutr; 2024 Apr; 63(3):751-762. PubMed ID: 38157050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined Loss of Ghrelin Receptor and Cannabinoid CB1 Receptor in Mice Decreases Survival but does not Additively Reduce Body Weight or Eating.
    Mani BK; Castorena CM; Vianna CR; Lee CE; Metzger NP; Vijayaraghavan P; Osborne-Lawrence S; Elmquist JK; Zigman JM
    Neuroscience; 2020 Nov; 447():53-62. PubMed ID: 31520709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hindbrain ghrelin and liver-expressed antimicrobial peptide 2, ligands for growth hormone secretagogue receptor, bidirectionally control food intake.
    Wald HS; Ghidewon MY; Hayes MR; Grill HJ
    Am J Physiol Regul Integr Comp Physiol; 2023 Apr; 324(4):R547-R555. PubMed ID: 36847494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protocol for assessing the effects of exogenous hormone administration on human postprandial glucose metabolism, appetite sensations, and food intake.
    Hagemann CA; Gasbjerg LS; Christensen MB; Knop FK
    STAR Protoc; 2023 Mar; 4(1):102070. PubMed ID: 36853704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The dietary regulation of LEAP2 depends on meal composition in mice.
    Gradel AKJ; Holm SK; Byberg S; Merkestein M; Hogendorf WFJ; Lund ML; Buijink JA; Damgaard J; Lykkesfeldt J; Holst B
    FASEB J; 2023 Jun; 37(6):e22923. PubMed ID: 37104087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver-expressed antimicrobial peptide 2 antagonizes the effect of ghrelin in rodents.
    Islam MN; Mita Y; Maruyama K; Tanida R; Zhang W; Sakoda H; Nakazato M
    J Endocrinol; 2020 Jan; 244(1):13-23. PubMed ID: 31539874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.